国药现代子公司获盐酸氢吗啡酮注射液药品注册证书

Core Viewpoint - The company, China National Pharmaceutical Group Modern (国药现代), announced that its wholly-owned subsidiary, China National Pharmaceutical Group Industry Co., Ltd. (国药工业), has received approval from the National Medical Products Administration for the drug registration certificate of Hydromorphone Hydrochloride Injection [1] Group 1 - The drug Hydromorphone, also known as dihydromorphinone, is a semi-synthetic opioid alkaloid that has been in clinical use since 1926 [1] - Hydromorphone Hydrochloride Injection is indicated for patients requiring opioid analgesia [1]